CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation Cardiopulmonary Exercise Testing: What Is its Value? Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk Volume brings value

Review ArticleApril 2020

JOURNAL:JACC Article Link

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

B Bikdeli, MV Madhavan, D Jimenez et al. Keywords: COVID-19; SARS-CoV-2; thrombosis; antithrombotic therapy; anticoagulant; antiplatelet

Full Text PDF